Geneva (Reuters) – Global demand for COVID-19 testing devices is expected to outstrip supply for a long time, Roche Chief Executive Severin Schwan said on Tuesday.
“We still have little information about duration and efficacy of vaccines (…) So diagnostics will remain very important, not only for the months to come but the years to come,” Schwan said in a briefing of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA).
(Reporting by Stephanie Nebehay in Geneva, John Miller in Zurich and Matthias Blamont in Paris; Editing by David Goodman)
